Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olfa Derbel

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Pathology|January 1, 2014
The clinician's perspective on sarcoma pathology reporting: impact on treatment decisions?Jean-Yves Blay, Olfa Derbel, Isabelle Ray-Coquard
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Do our current clinical trial designs help to guide clinical practice?Jean-Yves Blay, Olfa Derbel, Isabelle Ray-Coquard
Bonekey Reports|December 24, 2013
Giant-cell tumor of bone, anti-RANKL therapyArmelle Dufresne, Olfa Derbel, Philippe Cassier, et al.
Clinical Sarcoma Research|May 14, 2015
Eight years tumor control with pazopanib for a metastatic resistant epithelioid hemangioendotheliomaOlivia Bally, Louis Tassy, Bertrand Richioud, et al.
BMC Cancer|March 19, 2013
Outcome of patients with advanced solitary fibrous tumors: the Centre Léon Bérard experienceAlice Levard, Olfa Derbel, Pierre Méeus, et al.
Journal of Geriatric Oncology|September 28, 2013
Sorafenib and sunitinib for elderly patients with renal cell carcinomaOlfa Derbel Miled, Christine Dionne, Catherine Terret, et al.
Clinical Pharmacology : Advances and Applications|December 4, 2012
Pazopanib for the treatment of soft-tissue sarcomaPierre Heudel, Philippe Cassier, Olfa Derbel, et al.
BMC Cancer|April 27, 2013
Impact of KRAS, BRAF and PI3KCA mutations in rectal carcinomas treated with neoadjuvant radiochemotherapy and surgeryOlfa Derbel, Qing Wang, Françoise Desseigne, et al.
Hematology (Amsterdam, Netherlands)|June 19, 2010
A single dose pegfilgrastim for supporting neutrophil recovery in patients treated for high-risk acute myeloid leukemia by the EMA 2000 scheduleOlfa Derbel, Giovanna Cannas, Quoc-Hung Le, et al.
BMC Cancer|November 3, 2011
Results of combined treatment of anaplastic thyroid carcinoma (ATC)Olfa Derbel, Sami Limem, Céline Ségura-Ferlay, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Pathology|January 1, 2014
The clinician's perspective on sarcoma pathology reporting: impact on treatment decisions?Jean-Yves Blay, Olfa Derbel, Isabelle Ray-Coquard
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Do our current clinical trial designs help to guide clinical practice?Jean-Yves Blay, Olfa Derbel, Isabelle Ray-Coquard
Bonekey Reports|December 24, 2013
Giant-cell tumor of bone, anti-RANKL therapyArmelle Dufresne, Olfa Derbel, Philippe Cassier, et al.
Clinical Sarcoma Research|May 14, 2015
Eight years tumor control with pazopanib for a metastatic resistant epithelioid hemangioendotheliomaOlivia Bally, Louis Tassy, Bertrand Richioud, et al.
BMC Cancer|March 19, 2013
Outcome of patients with advanced solitary fibrous tumors: the Centre Léon Bérard experienceAlice Levard, Olfa Derbel, Pierre Méeus, et al.
Journal of Geriatric Oncology|September 28, 2013
Sorafenib and sunitinib for elderly patients with renal cell carcinomaOlfa Derbel Miled, Christine Dionne, Catherine Terret, et al.
Clinical Pharmacology : Advances and Applications|December 4, 2012
Pazopanib for the treatment of soft-tissue sarcomaPierre Heudel, Philippe Cassier, Olfa Derbel, et al.
BMC Cancer|April 27, 2013
Impact of KRAS, BRAF and PI3KCA mutations in rectal carcinomas treated with neoadjuvant radiochemotherapy and surgeryOlfa Derbel, Qing Wang, Françoise Desseigne, et al.
Hematology (Amsterdam, Netherlands)|June 19, 2010
A single dose pegfilgrastim for supporting neutrophil recovery in patients treated for high-risk acute myeloid leukemia by the EMA 2000 scheduleOlfa Derbel, Giovanna Cannas, Quoc-Hung Le, et al.
BMC Cancer|November 3, 2011
Results of combined treatment of anaplastic thyroid carcinoma (ATC)Olfa Derbel, Sami Limem, Céline Ségura-Ferlay, et al.
Pageof 3